Stimart Tryn 4
4 · AbCellera Biologics Inc. · Filed Jan 5, 2026
Insider Transaction Report
Form 4
Stimart Tryn
Chief Legal Officer
Transactions
- Award
Share option (right to buy)
2026-01-01+539,265→ 4,646,012 totalExercise: $3.42Exp: 2036-01-01→ Common Shares (539,265 underlying)
Footnotes (1)
- [F1]The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date.